AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$NTHI

CHEN THOMAS C purchased $70K of NTHI (indirect holdings)

CHEN THOMAS C (CEO) purchased 12,757 indirectly-held shares of NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) at $5.49 on 2026-08-18.

Original reporting
SEC EDGAR · CHEN THOMAS C
Published Aug 21, 2026, 1:15 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 21, 2026, 1:32 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$NTHI
Neutral
medium confidence
Mentioned
$NTHI
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NTHINeutralLow
01

Why it matters

A small insider buy by the CEO may be viewed as a positive signal but is unlikely to affect the stock materially.

02

Market read

Limited relevance; primarily of interest to shareholders tracking insider activity.

03

What to watch

Potential upcoming corporate actions not disclosed could motivate the buy.

Relevance 4/10Novelty 4/10Timing: transaction dated 2026-08-18, filed 2026-08-20

Background

Form 4 filings disclose insider transactions; this is the first public report of this purchase.

Company-level read

Ticker impact

$NTHINeutralMedium confidence
Context

CEO Chen Thomas C purchased 12,757 shares for $69,998, increasing his stake to 13,705 shares.

Expected impact

Minimal short-term impact; may provide slight bullish bias.

Evidence & confidence

Purchase amount is under $100k for a micro‑cap, typical for 10b5‑1 plans, limited market effect.

Market effects

Sector

None

Regional

None

Global

None

Counterpoint

What could challenge this read

Insider purchase may be routine; investors should not overreact.

Key entities

  • Company
    NeonC Technologies Holdings, Inc.

    Issuer of the Form 4 filing.

  • Person
    Chen Thomas C

    CEO and insider purchaser.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

NTHI insider trading history →

Related articles

$NTHIMedAI 8/10

NeOnc Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress

NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NeOnc Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress Updated NEO100 Phase 1/2a results and NEO212 Phase 1 data to be presented at the Society for Neuro-Oncology Annual Meeting on November 13 CALABASAS, Calif., Nov.

SEC EDGAR 8-K
$NTHIMedAI 8/10

NeOnc to Present NEO100 and NEO212 Data at Neuro-Oncology Meeting

NeOnc Technologies (NTHI) will present data on its NEO100 and NEO212 programs at the Society for Neuro-Oncology meeting. NEO100 data includes Phase 1/2a study and compassionate use results for recurrent IDH1-mutant astrocytoma. NEO212 data covers Phase 1 safety, pharmacokinetics, and early activity signals in TMZ-resistant recurrent GBM and brain metastases. Both posters are scheduled for November 13, 2026.

tradingview.com
$NTHILowAI 8/10

NeOnc Reports Early Clinical Improvement in First Child Treated with NEO100 Under Compassionate Use in Abu Dhabi

NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 NeOnc Reports Early Clinical Improvement in First Child Treated with NEO100 Under Compassionate Use in Abu Dhabi Treating physicians report that a critically ill three-year-old boy is breathing independently and showing renewed movement following initiation of invest

SEC EDGAR 8-K